Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · 2018 · 21 citations · 30 references
MedicineCardiologySurgeryCardiothoracic SurgeryClinical CardiologyPulmonary Function TestingAortic RegurgitationCardiac Valve SurgeryEchocardiographic Hemodynamic AssessmentTranscatheter Aortic Valve ReplacementTranscatheter Valve TherapyTricuspid RegurgitationAortic Regurgitation Severity AssessmentAortic Valve Disease PrognosisEchocardiographic Severity AssessmentLong-term Outcome PredictionPrognosis Of Tricuspid RegurgitationRight Ventricular Systolic FunctionSeverity AnalysisTricuspid Regurgitation Assessment
OBJECTIVE: This study sought to analyze outcomes in patients with moderate-severe tricuspid regurgitation (TR) undergoing transcatheter aortic valve replacement (TAVR). The consequences of uncorrected significant TR in patients undergoing TAVR remain undefined. METHODS: Between 2009 and 2014, 369 patients underwent TAVR at our institution, and 58 of these had baseline moderate-severe TR. Preoperative, 30-day, and 1-year transthoracic echocardiograms were analyzed. Predictors of persistent TR at 30 days and survival were assessed. RESULTS: Fifty-eight patients with baseline moderate-severe TR underwent TAVR. Transcatheter aortic valve replacement resulted in significant reductions in pulmonary artery pressures and TR severity (100% vs 64%; P < 0.001) at 30 days. This was sustained at 1 year and was associated with significant improvements in stroke volume index and New York Heart Association functional class. No changes in right ventricular function or size were noted. The only independent predictor of persistent moderate-severe TR at 30 days was preoperative atrial fibrillation [AF; odds ratio (OR), 4.56; 95% confidence interval, 1.1-18.3; P = 0.033]. Independent predictors of overall long-term survival included AF (OR, 0.41; P = 0.001) and chronic lung disease (OR, 0.47; P = 0.011), but not baseline moderate-severe TR. In patients with baseline moderate-severe TR, persistent moderate-severe TR at 30 days was associated with worsened overall survival (log-rank P = 0.02). CONCLUSIONS: Baseline moderate-severe TR is not uncommon in patients undergoing TAVR, and frequently improves. However, the presence of AF suggests that that TR is likely to persist after TAVR and is also indicative of a poor long-term outcome. Whether redirecting such patients to surgery for concomitant tricuspid valve repair will further improve outcomes requires further study.
30
Lawrence Rudski, Wyman W. Lai, Jonathan Afilalo et al. · Journal of the American Society of Echocardiography · 2010 · 7K citations · Full text
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
Craig R. Smith, Martin B. Leon, Michael J. Mack et al. · New England Journal of Medicine · 2011 · 6.3K citations · Full text
Medicine, Cardiology, Surgery +13
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
Martin B. Leon, Craig R. Smith, Michael J. Mack et al. · New England Journal of Medicine · 2016 · 5K citations · Full text
Medicine, Cardiology, Surgery +13